Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Amortization of Deferred Charges: 2010-2024

Historic Amortization of Deferred Charges for Select Medical Holdings (SEM) over the last 15 years, with FY2024 value amounting to $3.0 million.

  • Select Medical Holdings' Amortization of Deferred Charges fell 38.12% to $784000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 353.25%. This contributed to the annual value of $3.0 million for FY2024, which is 1193.8% up from last year.
  • Latest data reveals that Select Medical Holdings reported Amortization of Deferred Charges of $3.0 million as of FY2024, which was up 1193.8% from $2.6 million recorded in FY2023.
  • Select Medical Holdings' Amortization of Deferred Charges' 5-year high stood at $3.0 million during FY2024, with a 5-year trough of $2.2 million in FY2020.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $2.3 million (2022), whereas its average is $2.5 million.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first plummeted by 8111.71% in 2020, then soared by 1650.53% in 2023.
  • Over the past 5 years, Select Medical Holdings' Amortization of Deferred Charges (Annual) stood at $2.2 million in 2020, then grew by 1.51% to $2.2 million in 2021, then grew by 2.48% to $2.3 million in 2022, then grew by 16.51% to $2.6 million in 2023, then increased by 11.94% to $3.0 million in 2024.
  • Its last three reported values are $3.0 million in FY2024, $2.6 million for FY2023, and $2.3 million during FY2022.